Aayush Wellness Annual Report
Aayush Wellness Limited has submitted its Annual Report for the financial year 2025-26. The report includes financial statements, statutory reports, and corporate information.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements with these filters
Aayush Wellness Limited has submitted its Annual Report for the financial year 2025-26. The report includes financial statements, statutory reports, and corporate information.
Aayush Wellness Limited has issued the notice for its 42nd Annual General Meeting scheduled for September 29, 2026. The meeting will be held via video conferencing.
Aayush Wellness Limited announced the re-appointment of Gavadu Patil as Non-Executive Non-Independent Director and the appointment of A. Raghavendra Rao & Associates as Statutory Auditor.
Aayush Wellness approved the reappointment of a director and the appointment of new statutory auditors. The board also scheduled the 42nd Annual General Meeting.
Aayush Wellness confirmed to BSE that they have no undisclosed information that would impact the company's recent share price movement or performance.
Aayush Wellness Limited has launched its new Lung Care Tablets, expanding its preventive healthcare portfolio. This product targets consumers concerned about respiratory health.
Aayush Wellness Limited announced postal ballot results with shareholders approving the appointment of statutory auditors and two non-executive directors. All three ordinary resolutions passed with significant majority.
Aayush Wellness reported Q1 FY27 consolidated revenue of ₹33.11 Crore, reflecting 46% YoY growth. Consolidated PAT stood at ₹1.42 Crore for the quarter.
Aayush Wellness Ltd reported revenue from operations of ₹33.1 Cr (+46.5% YoY) and net profit of ₹1.4 Cr (+16.7% YoY) for Q1 FY27.
Aayush Wellness Ltd has scheduled a Board Meeting for August 13, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026.
Aayush Wellness Ltd has filed its shareholding pattern for the quarter ended June 30, 2026. This is a standard regulatory filing under Regulation 31.
Aayush Wellness Limited issued a Postal Ballot Notice for shareholder approval. Agenda includes appointing new Statutory Auditors and regularising two Non-Executive Directors' appointments.
Aayush Wellness approved the appointment of new statutory auditors and the regularisation of two non-executive directors. A postal ballot process for member approval was also initiated.